gallium Ga 68-NODAGA-Ac-Cys-ZEGFR:1907

{
  "id": "MLC-T-ONC-013861",
  "term": "gallium Ga 68-NODAGA-Ac-Cys-ZEGFR:1907",
  "field": "Oncology and biomedicine",
  "definition": "A radiolabeled recombinant EGFR-specific affibody molecule composed of an epidermal growth factor receptor (EGFR)-targeting protein, the anti-EGFR affibody ZEGFR:1907 with an acetylated cysteine (Ac-Cys) at the N terminal of the affibody, and conjugated to the radioisotope gallium Ga 68, via the chelating agent NODAGA (1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid), with potential use for imaging EGFR-expressing tumor cells upon positron emission tomography (PET). Upon administration of gallium Ga 68-NODAGA-Ac-Cys-ZEGFR:1907, the ZEGFR:1907 affibody molecule moiety targets and binds to the extracellular domain (ECD) of EGFR expressed on various tumor cell types. Upon PET, EGFR-expressing tumor cells can be visualized. EGFR, frequently overexpressed in cancers, plays important roles in cell proliferation, survival, adhesion, migration, and differentiation. The affibody protein scaffold is based on the Z-domain, which is derived from one of the immunoglobulin (Ig) G-binding domains of staphylococcal protein A.",
  "synonyms": [
    "68Ga-NODAGA-Ac-Cys-ZEGFR:1907",
    "[68Ga]-labeled anti-EGFR affibody molecule Ac-Cys-ZEGFR:1907",
    "gallium Ga 68-NODAGA-Ac-Cys-Z(EGFR:1907)"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/gallium-ga-68-nodaga-ac-cys-zegfr-1907/"
}